Ventilatory inefficiency as a limiting factor for exercise in patients with COPD.

Respir Care

Universidad del Desarrollo, Santiago, Chile.

Published: April 2012

AI Article Synopsis

  • Ventilatory inefficiency, indicated by the V_dot(E)/V_dot(CO(2)) ratio, is linked to increased respiratory demands and reduced exercise capacity in COPD patients due to factors like dead space and dynamic hyperinflation.
  • A study of 35 COPD patients demonstrated that those with elevated ventilatory inefficiency experienced significant decreases in maximal oxygen consumption, power output, and overall exercise performance during stress tests.
  • The findings suggest that assessing ventilatory inefficiency can provide insights into exercise limitations and the underlying pathophysiology of COPD.

Article Abstract

Background: Ventilatory inefficiency increases ventilatory demand; corresponds to an abnormal increase in the ratio of minute ventilation (V_dot(E)) to CO(2) production (V_dot(CO(2))); represents increased dead space, deregulation of respiratory control, and early lactic threshold; and is associated with expiratory flow limitation that enhances dynamic hyperinflation and may limit exercise capacity.

Objective: To evaluate the influence of ventilatory inefficiency over exercise capacity in COPD patients.

Methods: Prospective study of 35 COPD subjects with different levels of severity, in whom cardiopulmonary stress test was performed. Ventilatory inefficiency was represented by the V_dot(E) /V_dot(CO(2)) relation. Its influence over maximal oxygen consumption (V_dot(O(2))max), power (W), and ventilatory threshold was evaluated. Surrogate parameters of cardiac function, like oxygen pulse (V_dot(O(2))/heart rate) and circulatory power (%V_dot(O(2))max × peak systolic pressure), were also evaluated.

Results: Cardiopulmonary stress test was stopped due to dyspnea with elevated V_dot(E) and marked reduction of breathing reserve. A severe increase in V_dot(CO(2)) (mean ± SD 35.9 ± 5.6), a decrease of V_dot(O(2)) (mean ± SD 75.2 ± 20%), and a decrease of W (mean ± SD 68.6 ± 23.3%) were demonstrated. Twenty-eight patients presented dynamic hyperinflation. Linear regression showed a reduction of 2.04% on V_dot(O(2>))max (P < .001), 2.6% on W (P < .001), 1% on V_dot(O(2))/heart rate (P = .049), and 322.7 units on circulatory power (P = .02) per each unit of increment in V_dot(E)/V_dot(CO(2)), respectively.

Conclusions: Ventilatory inefficiency correlates with a reduction in exercise capacity in COPD patients. Including this parameter in the evaluation of exercise limitation in this patient population may mean a contribution toward the understanding of its pathophysiology.

Download full-text PDF

Source
http://dx.doi.org/10.4187/respcare.01342DOI Listing

Publication Analysis

Top Keywords

ventilatory inefficiency
20
dynamic hyperinflation
8
exercise capacity
8
capacity copd
8
cardiopulmonary stress
8
stress test
8
v_doto2/heart rate
8
circulatory power
8
ventilatory
7
exercise
5

Similar Publications

Time-varying intensity of ventilatory inefficiency and mortality in patients with acute respiratory distress syndrome.

Ann Intensive Care

January 2025

Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, No. 87, Dingjiaqiao Road, Gulou District, Nanjing, 210009, People's Republic of China.

Background: The association between bedside ventilatory parameters-specifically arterial carbon dioxide pressure (PaCO) and ventilatory ratio (VR)-and mortality in patients with acute respiratory distress syndrome (ARDS) remains a topic of debate. Additionally, the persistence of this association over time is unclear. This study aims to investigate the relationship between 28-day mortality in ARDS patients and their longitudinal exposure to ventilatory inefficiency, as reflected by serial measurements of PaCO and VR.

View Article and Find Full Text PDF

Right ventricular coupling predicts cardiopulmonary fitness in cardiac transthyretin amyloidosis.

Amyloid

December 2024

Department of Cardiology, German Heart Centre Munich, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany.

Background: Wild-type transthyretin cardiac amyloidosis (ATTRwt) is an infiltrative disease leading to restrictive cardiomyopathy. We aimed to characterise exercise capacity in ATTRwt and to identify predictors of cardiopulmonary fitness, focusing on echocardiographic and clinical parameters.

Methods: We studied 110 ATTRwt patients from a prospective single-centre registry (2020-2024) by cardiopulmonary exercise testing (CPET).

View Article and Find Full Text PDF
Article Synopsis
  • Atrial fibrillation-induced cardiomyopathy (AIC) is characterized by a drop in left ventricular ejection fraction (LVEF) due to AF, but the reasons why some patients develop AIC are still unclear.* -
  • The study hypothesizes that subtle heart muscle issues exist before LVEF decreases; therefore, a detailed examination of heart function following successful catheter ablation is essential to identify these features.* -
  • Results show that out of 41 participants, 82.9% recovered LVEF post-ablation, yet many still had signs of heart dysfunction, with significant portions exhibiting elevated NT-proBNP levels, ongoing heart failure symptoms, and impaired heart performance despite normalization of LVEF.*
View Article and Find Full Text PDF

Pulmonary gas exchange in relation to exercise pulmonary hypertension in patients with heart failure with preserved ejection fraction.

Eur Respir J

November 2024

Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital Dallas and Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA

Background: Exercise pulmonary hypertension (ePH), defined as a mean pulmonary artery pressure (mPAP)/cardiac output (Qc) slope >3 WU during exercise, is common in patients with heart failure with preserved ejection fraction (HFpEF). However, the pulmonary gas exchange-related effects of an exaggerated ePH (EePH) response are not well-defined, especially in relation to dyspnea on exertion (DOE) and exercise intolerance.

Methods: 48 HFpEF patients underwent invasive (pulmonary and radial artery catheters) constant-load (20W) and maximal incremental cycle testing.

View Article and Find Full Text PDF

Do Hemodynamic Definitions of Chronic Thromboembolic Pulmonary Hypertension Distinguish Between Distinct Phenotypes of Chronic Thromboembolic Pulmonary Disease?

Ann Am Thorac Soc

October 2024

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom of Great Britain and Northern Ireland.

Background: Chronic thromboembolic pulmonary disease (CTEPD) is defined by chronic organized thrombi in the pulmonary circulation without or with pulmonary hypertension (CTEPH). The current definition of CTEPH has adopted lower mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR) thresholds. Our aim was to identify its impact on the characterization of patients with CTEPD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!